Keywords: Karo Bio, Eprotirone, Split up, Cholesterol lowerer

Karo Bio drops eprotirome and split up plans

Article | 15 February 2012

Print This

There was a double-dose of bad news for Sweden’s Karo Bio (STO: KARO), which this week said it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in